Search Results - "Pohorille, Alicia"

The Localization of the Brain-Specific Inorganic Phosphate Transporter Suggests a Specific Presynaptic Role in Glutamatergic Transmission by Bellocchio, Elizabeth E, Hu, Hailan, Pohorille, Alicia, Chan, June, Pickel, Virginia M, Edwards, Robert H

“…Molecular cloning has recently identified a vertebrate brain-specific Na+-dependent inorganic phosphate transporter (BNPI). BNPI has strong sequence similarity…”
Get full text

The Dopamine Transporter: Comparative Ultrastructure of Dopaminergic Axons in Limbic and Motor Compartments of the Nucleus Accumbens by Nirenberg, Melissa J, Chan, June, Pohorille, Alicia, Vaughan, Roxanne A, Uhl, George R, Kuhar, Michael J, Pickel, Virginia M

“…The dopamine transporter (DAT) regulates extracellular dopamine concentrations, transports neurotoxins, and acts as a substrate for cocaine reinforcement…”
Get full text

P-23: Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), on blood pressure in patients with mild to moderate hypertension - a large Aceon® Community Trial (ACT) with 8083 patients by Weber, Michael, Pohorille, Alicia, Turlapaty, Prasad

“…The effect of perindopril, an ACE-I, on sitting blood pressure (BP) was investigated in a 12 week, open-label, multicenter, general practice setting in 8083…”
Get full text

P-22: Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 2269 elderly hypertensive patients: subgroup analysis of a 12-week, open-label, Aceon® Community Trial (ACT) by Neutel, Joel, Pohorille, Alicia, Carter, Fred

“…There is little data on the management of elderly hypertensive patients in family practice. Furthermore, it has been well demonstrated that treatment of these…”
Get full text

P-21: Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in the treatment of 1022 African-American patients with mild to moderate hypertension: subgroup analysis of a 12 week, open-label, Aceon®Community Trial (ACT) by Julius, Stevo, Pohorille, Alicia, Rokette, Staci

“…There is an ongoing controversy regarding the efficacy of ACE-I in the African-American (AA) population. In this study, the efficacy and safety of perindopril…”
Get full text

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in the treatment of 1022 African-American patients with mild to moderate hypertension: subgroup analysis of a 12 week, open-label, Aceon®Community Trial (ACT) by Julius, Stevo, Pohorille, Alicia, Rokette, Staci

Get full text

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT) by Cohn, Jay N., Pohorille, Alicia, Golod, David

Get full text

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 2269 elderly hypertensive patients: subgroup analysis of a 12-week, open-label, Aceon® Community Trial (ACT) by Neutel, Joel, Pohorille, Alicia, Carter, Fred

Get full text

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), on blood pressure in patients with mild to moderate hypertension - a large Aceon® Community Trial (ACT) with 8083 patients by Weber, Michael, Pohorille, Alicia, Turlapaty, Prasad

Get full text

P-24: Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT) by Cohn, Jay N., Pohorille, Alicia, Golod, David

“…The contribution of hypertension to the cardiovascular events in diabetes resulted in recommendations for aggressive treatment in patients with diabetes and…”
Get full text